Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A
Biomarkers play a pivotal role in the management of rheumatoid arthritis (RA) by facilitating early diagnosis and 'treat to the target.' However, no gold standard biomarker has been identified for monitoring the disease activity in RA. Cytokines, a diverse group of small protein molecules...
Gespeichert in:
| Veröffentlicht in: | PloS one 2021-01, Vol.16 (1), p.e0246111-e0246111 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0246111 |
|---|---|
| container_issue | 1 |
| container_start_page | e0246111 |
| container_title | PloS one |
| container_volume | 16 |
| creator | Dissanayake, Keerthie Jayasinghe, Chandrika Wanigasekara, Priyani Sominanda, Ajith |
| description | Biomarkers play a pivotal role in the management of rheumatoid arthritis (RA) by facilitating early diagnosis and 'treat to the target.' However, no gold standard biomarker has been identified for monitoring the disease activity in RA. Cytokines, a diverse group of small protein molecules secreted by peripheral blood mononuclear cells (PBMCs), play a pivotal role in pathogenesis and disease progression in RA. Research is currently underway to find out the applicability of cytokines as biomarkers in RA. This study aimed to quantify the PBMCs that secrete four types of cytokines; TNF-α, IL-1β, IL-10 and IL-17A in two cohorts of active RA patients (early RA patients and established RA patients), compared to healthy controls (HC), using the enzyme-linked immunosorbent spot (ELISPOT) assay, and to assess their association with measures of disease activity of RA. Patients were recruited from outpatient rheumatology clinics, and the disease activity was assessed using single and composite measures of disease activity. The cytokine expression was evaluated using freshly separated PBMCs from whole blood of RA patients using the ELISPOT assay. The number of PBMCs (counted as spot-forming cells (SFCs) per 105 PBMCs) that secreted the cytokine of interest were statistically significantly higher in early RA patients, compared to HC, for IL-17A (P |
| doi_str_mv | 10.1371/journal.pone.0246111 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2481100982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c9a8a835884b4bb3aeca0e8dafb67d67</doaj_id><sourcerecordid>2481100982</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-811e56d998441fcfa13e5e2f25bf1b4ade669e8b9ae430465556d237c1fb734f3</originalsourceid><addsrcrecordid>eNptksFu1DAQhiMEoqXwBggsceFAljh2nIQDUlW1sNIKOJSzNXYmXe868WInKy1vBVfeoc-E091WLeLkkeefb2Z-TZK8pNmMspK-X7nR92BnG9fjLMu5oJQ-So5pzfJU5Bl7fC8-Sp6FsMqyglVCPE2OGON1yWp-nPz55gbsBwOWwGZjjQZlrBl2xLVE7wa3Nj0GAoEo4zrwa_RhSjUmIAQkoAezneSmJ36JYweDMw0BPyy9GUz4QM77n7sOU2v6NTbEdN3Yu-C8ik1J2LghsgPsUhVpDcEt2BEG4_qpyeWXi_T61zsyX6T0-vf-zQj0zU1Unj5PnrRgA744vCfJ94vzy7PP6eLrp_nZ6SLVRS6GtKIUC9HUdcU5bXULlGGBeZsXqqWKQ4NC1FipGpCzjIuiiOqclZq2qmS8ZSfJ6z13Y12QB9-DzHkkZ1ld5VEx3ysaByu58SZatZMOjLz5cP5KRkuMtih1DRVUrKgqrrhSDFBDhlUDrRJlI8rI-njoNqoOGx2N8mAfQB9merOUV24ry4qVcfoIeHsAePdjxDDIzgSN1kKPbtzPLQpaZ5P0zT_S_2_H9yrtXQge27thaCanW7ytktMtysMtxrJX9xe5K7o9PvYXcBnhXA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2481100982</pqid></control><display><type>article</type><title>Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Dissanayake, Keerthie ; Jayasinghe, Chandrika ; Wanigasekara, Priyani ; Sominanda, Ajith</creator><creatorcontrib>Dissanayake, Keerthie ; Jayasinghe, Chandrika ; Wanigasekara, Priyani ; Sominanda, Ajith</creatorcontrib><description>Biomarkers play a pivotal role in the management of rheumatoid arthritis (RA) by facilitating early diagnosis and 'treat to the target.' However, no gold standard biomarker has been identified for monitoring the disease activity in RA. Cytokines, a diverse group of small protein molecules secreted by peripheral blood mononuclear cells (PBMCs), play a pivotal role in pathogenesis and disease progression in RA. Research is currently underway to find out the applicability of cytokines as biomarkers in RA. This study aimed to quantify the PBMCs that secrete four types of cytokines; TNF-α, IL-1β, IL-10 and IL-17A in two cohorts of active RA patients (early RA patients and established RA patients), compared to healthy controls (HC), using the enzyme-linked immunosorbent spot (ELISPOT) assay, and to assess their association with measures of disease activity of RA. Patients were recruited from outpatient rheumatology clinics, and the disease activity was assessed using single and composite measures of disease activity. The cytokine expression was evaluated using freshly separated PBMCs from whole blood of RA patients using the ELISPOT assay. The number of PBMCs (counted as spot-forming cells (SFCs) per 105 PBMCs) that secreted the cytokine of interest were statistically significantly higher in early RA patients, compared to HC, for IL-17A (P<0.05). Such an increased number of SFCs was not observed in the established RA group, compared to controls, for any of the cytokines tested. The correlation analysis showed that IL-17A is having a moderate correlation (Spearman`s ρ, p <0.05) with five clinical measures of disease activity, including disease activity score 28 (DAS28). According to the multivariable linear regression models, IL17A was a good predictor of both the disease activity score 28 (DAS28) and clinical disease activity index (CDAI). In conclusion, IL-17A has potential applicability as a biomarker of disease activity of RA.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0246111</identifier><identifier>PMID: 33497394</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Antibodies ; Antigens ; Arthritis ; Bioassays ; Biology and Life Sciences ; Biomarkers ; C-reactive protein ; Chronic infection ; Citrulline ; Cytokines ; Erythrocyte sedimentation rate ; Erythrocytes ; Fibrinogen ; IL-1β ; Interleukin 10 ; Medicine ; Medicine and Health Sciences ; Methotrexate ; Patients ; Physical Sciences ; Prednisolone ; Remission ; Research and Analysis Methods ; Rheumatoid arthritis ; Rheumatoid factor ; Rheumatology ; Sampling methods ; Sampling techniques ; Signs and symptoms ; Steroid hormones ; Steroids ; Teaching hospitals ; Tumor necrosis factor-α</subject><ispartof>PloS one, 2021-01, Vol.16 (1), p.e0246111-e0246111</ispartof><rights>2021 Dissanayake et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Dissanayake et al 2021 Dissanayake et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-811e56d998441fcfa13e5e2f25bf1b4ade669e8b9ae430465556d237c1fb734f3</citedby><cites>FETCH-LOGICAL-c526t-811e56d998441fcfa13e5e2f25bf1b4ade669e8b9ae430465556d237c1fb734f3</cites><orcidid>0000-0002-8717-0103</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837465/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837465/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33497394$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dissanayake, Keerthie</creatorcontrib><creatorcontrib>Jayasinghe, Chandrika</creatorcontrib><creatorcontrib>Wanigasekara, Priyani</creatorcontrib><creatorcontrib>Sominanda, Ajith</creatorcontrib><title>Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Biomarkers play a pivotal role in the management of rheumatoid arthritis (RA) by facilitating early diagnosis and 'treat to the target.' However, no gold standard biomarker has been identified for monitoring the disease activity in RA. Cytokines, a diverse group of small protein molecules secreted by peripheral blood mononuclear cells (PBMCs), play a pivotal role in pathogenesis and disease progression in RA. Research is currently underway to find out the applicability of cytokines as biomarkers in RA. This study aimed to quantify the PBMCs that secrete four types of cytokines; TNF-α, IL-1β, IL-10 and IL-17A in two cohorts of active RA patients (early RA patients and established RA patients), compared to healthy controls (HC), using the enzyme-linked immunosorbent spot (ELISPOT) assay, and to assess their association with measures of disease activity of RA. Patients were recruited from outpatient rheumatology clinics, and the disease activity was assessed using single and composite measures of disease activity. The cytokine expression was evaluated using freshly separated PBMCs from whole blood of RA patients using the ELISPOT assay. The number of PBMCs (counted as spot-forming cells (SFCs) per 105 PBMCs) that secreted the cytokine of interest were statistically significantly higher in early RA patients, compared to HC, for IL-17A (P<0.05). Such an increased number of SFCs was not observed in the established RA group, compared to controls, for any of the cytokines tested. The correlation analysis showed that IL-17A is having a moderate correlation (Spearman`s ρ, p <0.05) with five clinical measures of disease activity, including disease activity score 28 (DAS28). According to the multivariable linear regression models, IL17A was a good predictor of both the disease activity score 28 (DAS28) and clinical disease activity index (CDAI). In conclusion, IL-17A has potential applicability as a biomarker of disease activity of RA.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>Arthritis</subject><subject>Bioassays</subject><subject>Biology and Life Sciences</subject><subject>Biomarkers</subject><subject>C-reactive protein</subject><subject>Chronic infection</subject><subject>Citrulline</subject><subject>Cytokines</subject><subject>Erythrocyte sedimentation rate</subject><subject>Erythrocytes</subject><subject>Fibrinogen</subject><subject>IL-1β</subject><subject>Interleukin 10</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Methotrexate</subject><subject>Patients</subject><subject>Physical Sciences</subject><subject>Prednisolone</subject><subject>Remission</subject><subject>Research and Analysis Methods</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatoid factor</subject><subject>Rheumatology</subject><subject>Sampling methods</subject><subject>Sampling techniques</subject><subject>Signs and symptoms</subject><subject>Steroid hormones</subject><subject>Steroids</subject><subject>Teaching hospitals</subject><subject>Tumor necrosis factor-α</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptksFu1DAQhiMEoqXwBggsceFAljh2nIQDUlW1sNIKOJSzNXYmXe868WInKy1vBVfeoc-E091WLeLkkeefb2Z-TZK8pNmMspK-X7nR92BnG9fjLMu5oJQ-So5pzfJU5Bl7fC8-Sp6FsMqyglVCPE2OGON1yWp-nPz55gbsBwOWwGZjjQZlrBl2xLVE7wa3Nj0GAoEo4zrwa_RhSjUmIAQkoAezneSmJ36JYweDMw0BPyy9GUz4QM77n7sOU2v6NTbEdN3Yu-C8ik1J2LghsgPsUhVpDcEt2BEG4_qpyeWXi_T61zsyX6T0-vf-zQj0zU1Unj5PnrRgA744vCfJ94vzy7PP6eLrp_nZ6SLVRS6GtKIUC9HUdcU5bXULlGGBeZsXqqWKQ4NC1FipGpCzjIuiiOqclZq2qmS8ZSfJ6z13Y12QB9-DzHkkZ1ld5VEx3ysaByu58SZatZMOjLz5cP5KRkuMtih1DRVUrKgqrrhSDFBDhlUDrRJlI8rI-njoNqoOGx2N8mAfQB9merOUV24ry4qVcfoIeHsAePdjxDDIzgSN1kKPbtzPLQpaZ5P0zT_S_2_H9yrtXQge27thaCanW7ytktMtysMtxrJX9xe5K7o9PvYXcBnhXA</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Dissanayake, Keerthie</creator><creator>Jayasinghe, Chandrika</creator><creator>Wanigasekara, Priyani</creator><creator>Sominanda, Ajith</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8717-0103</orcidid></search><sort><creationdate>20210101</creationdate><title>Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A</title><author>Dissanayake, Keerthie ; Jayasinghe, Chandrika ; Wanigasekara, Priyani ; Sominanda, Ajith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-811e56d998441fcfa13e5e2f25bf1b4ade669e8b9ae430465556d237c1fb734f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>Arthritis</topic><topic>Bioassays</topic><topic>Biology and Life Sciences</topic><topic>Biomarkers</topic><topic>C-reactive protein</topic><topic>Chronic infection</topic><topic>Citrulline</topic><topic>Cytokines</topic><topic>Erythrocyte sedimentation rate</topic><topic>Erythrocytes</topic><topic>Fibrinogen</topic><topic>IL-1β</topic><topic>Interleukin 10</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Methotrexate</topic><topic>Patients</topic><topic>Physical Sciences</topic><topic>Prednisolone</topic><topic>Remission</topic><topic>Research and Analysis Methods</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatoid factor</topic><topic>Rheumatology</topic><topic>Sampling methods</topic><topic>Sampling techniques</topic><topic>Signs and symptoms</topic><topic>Steroid hormones</topic><topic>Steroids</topic><topic>Teaching hospitals</topic><topic>Tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dissanayake, Keerthie</creatorcontrib><creatorcontrib>Jayasinghe, Chandrika</creatorcontrib><creatorcontrib>Wanigasekara, Priyani</creatorcontrib><creatorcontrib>Sominanda, Ajith</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dissanayake, Keerthie</au><au>Jayasinghe, Chandrika</au><au>Wanigasekara, Priyani</au><au>Sominanda, Ajith</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>16</volume><issue>1</issue><spage>e0246111</spage><epage>e0246111</epage><pages>e0246111-e0246111</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Biomarkers play a pivotal role in the management of rheumatoid arthritis (RA) by facilitating early diagnosis and 'treat to the target.' However, no gold standard biomarker has been identified for monitoring the disease activity in RA. Cytokines, a diverse group of small protein molecules secreted by peripheral blood mononuclear cells (PBMCs), play a pivotal role in pathogenesis and disease progression in RA. Research is currently underway to find out the applicability of cytokines as biomarkers in RA. This study aimed to quantify the PBMCs that secrete four types of cytokines; TNF-α, IL-1β, IL-10 and IL-17A in two cohorts of active RA patients (early RA patients and established RA patients), compared to healthy controls (HC), using the enzyme-linked immunosorbent spot (ELISPOT) assay, and to assess their association with measures of disease activity of RA. Patients were recruited from outpatient rheumatology clinics, and the disease activity was assessed using single and composite measures of disease activity. The cytokine expression was evaluated using freshly separated PBMCs from whole blood of RA patients using the ELISPOT assay. The number of PBMCs (counted as spot-forming cells (SFCs) per 105 PBMCs) that secreted the cytokine of interest were statistically significantly higher in early RA patients, compared to HC, for IL-17A (P<0.05). Such an increased number of SFCs was not observed in the established RA group, compared to controls, for any of the cytokines tested. The correlation analysis showed that IL-17A is having a moderate correlation (Spearman`s ρ, p <0.05) with five clinical measures of disease activity, including disease activity score 28 (DAS28). According to the multivariable linear regression models, IL17A was a good predictor of both the disease activity score 28 (DAS28) and clinical disease activity index (CDAI). In conclusion, IL-17A has potential applicability as a biomarker of disease activity of RA.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33497394</pmid><doi>10.1371/journal.pone.0246111</doi><orcidid>https://orcid.org/0000-0002-8717-0103</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2021-01, Vol.16 (1), p.e0246111-e0246111 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_2481100982 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
| subjects | Antibodies Antigens Arthritis Bioassays Biology and Life Sciences Biomarkers C-reactive protein Chronic infection Citrulline Cytokines Erythrocyte sedimentation rate Erythrocytes Fibrinogen IL-1β Interleukin 10 Medicine Medicine and Health Sciences Methotrexate Patients Physical Sciences Prednisolone Remission Research and Analysis Methods Rheumatoid arthritis Rheumatoid factor Rheumatology Sampling methods Sampling techniques Signs and symptoms Steroid hormones Steroids Teaching hospitals Tumor necrosis factor-α |
| title | Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T19%3A43%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20applicability%20of%20cytokines%20as%20biomarkers%20of%20disease%20activity%20in%20rheumatoid%20arthritis:%20Enzyme-linked%20immunosorbent%20spot%20assay-based%20evaluation%20of%20TNF-%CE%B1,%20IL-1%CE%B2,%20IL-10%20and%20IL-17A&rft.jtitle=PloS%20one&rft.au=Dissanayake,%20Keerthie&rft.date=2021-01-01&rft.volume=16&rft.issue=1&rft.spage=e0246111&rft.epage=e0246111&rft.pages=e0246111-e0246111&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0246111&rft_dat=%3Cproquest_plos_%3E2481100982%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2481100982&rft_id=info:pmid/33497394&rft_doaj_id=oai_doaj_org_article_c9a8a835884b4bb3aeca0e8dafb67d67&rfr_iscdi=true |